Journal of Genetic Counseling

, Volume 26, Issue 3, pp 435–441 | Cite as

The Confluence of Psychiatric Symptoms and Neurodegenerative Disease: Impact on Genetic Counseling

  • Jill S. Goldman
  • Edward D. Huey
  • Deborah Z. Thorne
Case Presentation
  • 454 Downloads

Abstract

Hereditary neurodegenerative diseases can present with a psychiatric prodrome that overlaps with psychiatric symptoms that are not primary to these diseases. When individuals present for predictive testing while experiencing such symptoms, clinicians including genetic counselors, must proceed with caution and evaluate each situation on a case-by-case basis. Legitimate reasons may exist for moving forward with testing. Additionally predicting the consequences of testing is unrealistic so that the clinicians must do their best to prepare patients for both positive and negative results. A multidisciplinary team following the Huntington disease protocol remains the gold standard care for predictive testing for such patients. We discuss 3 case histories that demonstrate the complex nature of genetic counseling and testing in the presence of psychiatric symptoms, whether emanating from the disease itself or the results of living in an affected family.

Keywords

Huntington disease Frontotemporal dementia Neurodegenerative disease Psychiatric symptoms Predictive testing 

Notes

Compliance with Ethical Standards

Conflict of Interest

Jill Goldman, Edward Huey, and Deborah Thorne declare that they have no conflict of interest.

Human Studies and Informed Consent

Identities of patients has been altered to protect confidentiality.

References

  1. Almqvist, E. W., Brinkman, R. R., Wiggins, S., & Hayden, M. R. (2003). Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington’s disease. Clinical Genetics, 64, 300–309.CrossRefPubMedGoogle Scholar
  2. Arighi, A., Fumagalli, G. G., Jacini, F., Fenoglio, C., Ghezzi, C., Pietroboni, A. M., De Riz, M., et al. (2012). Early onset behavioral variant frontotemporal dementia due to C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations. Journal of Alzheimer's Disease, 31, 447–452.PubMedGoogle Scholar
  3. Bang, J., Spina, S., & Miller, B. L. (2015). Frontotemporal dementia. Lancet, 386, 1672–1682.CrossRefPubMedGoogle Scholar
  4. Block, N. R., Sha, S. J., Karydas, A. M., Fong, J. C., De May, M. G., Miller, B. L., & Rosen, H. J. (2016). Frontotemporal dementia and psychiatric illness: emerging clinical and biological links in gene carriers. American Journal of Geriatric Psychiatry, 24, 107–116.CrossRefPubMedGoogle Scholar
  5. Broadstock, M., Michie, S., & Marteau, T. (2000). Psychological consequences of predictive genetic testing: a systematic review. European Journal of Human Genetics, 8, 731–738.CrossRefPubMedGoogle Scholar
  6. Calvo, A., Moglia, C., Canosa, A., Cistaro, A., Valentini, C., Carrara, G., Soldano, E., et al. (2012). Amyotrophic lateral sclerosis/frontotemporal dementia with predominant manifestations of obsessive-compulsive disorder associated to GGGGCC expansion of the c9orf72 gene. Journal of Neurology, 259, 2723–2725.CrossRefPubMedGoogle Scholar
  7. Dale, M., Maltby, J., Shimozaki, S., Cramp, R., Rickards, H., & REGISTRY Investigators of the European Huntington’s Disease Network (2016). Disease stage, but not sex, predicts depression and psychological distress in Huntington’s disease: a European population study. Journal of Psychosomatic Research, 80, 17–22.CrossRefPubMedGoogle Scholar
  8. Decruyenaere, M., Evers-Kiebooms, G., Boogaerts, A., Cassiman, J. J., Cloostermans, T., Demyttenaere, K., Dom, R., Fryns, J. P., & Van den Berghe, H. (1996). Prediction of psychological functioning one year after the predictive test for Huntington’s disease and impact of the test result on reproductive decision making. Journal of Medical Genetics, 33(9), 737–743.CrossRefPubMedPubMedCentralGoogle Scholar
  9. Decruyenaere, M., Evers-Kiebooms, G., Cloostermans, T., Boogaerts, A., Demyttenaere, K., Dom, R., & Fryns, J. P. (2003). Psychological distress in the 5-year period after predictive testing for Huntington’s disease. European Journal of Human Genetics, 2003(11), 30–38.CrossRefGoogle Scholar
  10. Ducharme, S., Price, B. H., Larvie, M., Dougherty, D. D., & Dickerson, B. C. (2015). Clinical approach to the differential diagnosis between behavioral variant frontotemporal dementia and primary psychiatric disorders. American Journal of Psychiatry, 172, 827–837.CrossRefPubMedGoogle Scholar
  11. Duff, K., Paulsen, J. S., Beglinger, L. J., Langbehn, D. R., Wang, C., Stout, J. C., Ross, C. A., Predict-HD Investigators of the Huntington Study Group, et al. (2010). “Frontal” behaviors before the diagnosis of Huntington’s disease and their relationship to markers of disease progression: evidence of early lack of awareness. Journal of Neuropsychiatry and Clinical Neurosciences, 22, 196–207.CrossRefPubMedPubMedCentralGoogle Scholar
  12. Duisterhof, M., Trijsburg, R. W., Niermeijer, M. F., Roos, R. A., & Tibben, A. (2001). Psychological studies in Huntington’s disease: making up the balance. Journal of Medical Genetics, 38, 852–856.CrossRefPubMedPubMedCentralGoogle Scholar
  13. Epping, E. A., Mills, J. A., Beglinger, L. J., Fiedorowicz, J. G., Craufurd, D., Smith, M. M., Groves, M., PREDICT-HD Investigators and Coordinators of the Huntington Study Group, et al. (2013). Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study. Journal of Psychiatric Research, 47, 1423–1431.CrossRefPubMedGoogle Scholar
  14. Epping, E. A., Kim, J. I., Craufurd, D., Brashers-Krug, T. M., Anderson, K. E., McCusker, E., Luther, J., Long, J. D., Paulsen, J. S., & PREDICT-HD Investigators and Coordinators of the Huntington Study Group (2016). Longitudinal psychiatric symptoms in prodromal Huntington’s disease: a decade of data. American Journal of Psychiatry, 173, 184–192.CrossRefPubMedGoogle Scholar
  15. Evers-Kiebooms, G., & Decruyenaere, M. (1998). Predictive testing for Huntington’s disease: a challenge for persons at risk and for professionals. Patient Education and Counseling, 35, 15–26.CrossRefPubMedGoogle Scholar
  16. Floris, G., Borghero, G., Cannas, A., Di Stefano, F., Costantino, E., Murru, M. R., Brunetti, M., et al. (2012). Frontotemporal dementia with psychosis, parkinsonism, visuo-spatial dysfunction, upper motor neuron involvement associated to expansion of C9ORF72: a peculiar phenotype? Journal of Neurology, 259, 1749–1751.CrossRefPubMedPubMedCentralGoogle Scholar
  17. Galimberti, D., Fenoglio, C., Serpente, M., Villa, C., Bonsi, R., Arighi, A., Fumagalli, G. G., et al. (2013). Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation. Biological Psychiatry, 74, 384–391.CrossRefPubMedGoogle Scholar
  18. Galimberti, D., Reif, A., Dell’Orso, B., Palazzo, C., Villa, C., Fenoglio, C., Kittel-Schneider, S., et al. (2014a). C9ORF72 hexanucleotide repeat expansion as a rare cause of bipolar disorder. Bipolar Disorders, 16, 448–449.CrossRefPubMedGoogle Scholar
  19. Galimberti, D., Reif, A., Dell’Orso, B., Kittel-Schneider, S., Leonard, C., Herr, A., Palazzo, C., et al. (2014b). The C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia. Neurobiology of Aging, 35, 1214.CrossRefPubMedGoogle Scholar
  20. Galimberti, D., Dell’Osso, B., Altamura, A. C., & Scarpini, E. (2015). Psychiatric symptoms in frontotemporal dementia: epidemiology, phenotypes, and differential diagnosis. Biological Psychiatry, 78, 684–692.CrossRefPubMedGoogle Scholar
  21. Hallam, B.J., Silverberg, N.D., Lamarre, A.K., Mackenzie, I.R., Feldman, H.H. (2007–2008). Clinical presentation of prodromal frontotemporal dementia. American Journal of Alzheimer’s Disease and Other Dementias, 22, 456–467.Google Scholar
  22. Huey, E. D., Nagy, P. L., Rodriguez-Murillo, L., Manoochehri, M., Goldman, J., Lieberman, J., Karayiorgou, M., & Mayeux, R. (2013). C9ORF72 repeat expansions not detected in a group of patients with schizophrenia. Neurobiology of Aging, 34, 1309.CrossRefPubMedGoogle Scholar
  23. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington’s Chorea (1994). Guidelines for the molecular genetics predictive test in Huntington’s disease. Neurology, 44, 1533–1536.CrossRefGoogle Scholar
  24. Julien, C. L., Thompson, J. C., Wild, S., Yardumian, P., Snowden, J. S., Turner, G., & Craufurd, D. (2007). Psychiatric disorders in preclinical Huntington’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 78, 939–943.CrossRefPubMedGoogle Scholar
  25. Kertesz, A., Ang, L. C., Jesso, S., MacKinley, J., Baker, M., Brown, P., Shoesmith, C., et al. (2013). Psychosis and hallucinations in frontotemporal dementia with the C9ORF72 mutation: a detailed clinical cohort. Cognitive and Behavioral Neurology, 26, 146–154.CrossRefPubMedPubMedCentralGoogle Scholar
  26. Klitzman, R. (2009). “Am I my genes?”: questions of identity among individuals confronting genetic disease. Genetics in Medicine, 11, 880–889.CrossRefPubMedPubMedCentralGoogle Scholar
  27. Lanata, S. C., & Miller, B. L. (2016). The behavioural variant frontotemporal dementia (bvFTD) syndrome in psychiatry. Journal of Neurology, Neurosurgery and Psychiatry, 87, 501–511.CrossRefPubMedGoogle Scholar
  28. MacLeod, R., Tibben, A., Frontali, M., Evers-Kiebooms, G., Jones, A., Martinez-Descales, A., Roos, R. A., & Editorial Committee and Working Group ‘Genetic Testing Counselling’ of the European Huntington Disease Network (2013). Recommendations for the predictive genetic test in Huntington’s disease. Clinical Genetics, 83, 221–231.CrossRefPubMedGoogle Scholar
  29. Mand, C. M., Gillam, L., Duncan, R. E., & Delatycki, M. B. (2015). “I’m scared of being like mum”: the experience of adolescents living in families with Huntington disease. Journal of Huntington’s Disease, 4, 209–217.CrossRefPubMedGoogle Scholar
  30. Marshall, J., White, K., Weaver, M., Wetherill, L. F., Hui, S., Stout, J. C., Johnson, S. A., et al. (2007). Specific psychiatric manifestations among preclinical Huntington disease mutation carriers. Archives of Neurology, 64, 116–121.CrossRefPubMedGoogle Scholar
  31. Meisler, M. H., Grant, A. E., Jones, J. M., Lenk, G. M., He, F., Todd, P. K., Kamali, M., et al. (2013). C9ORF72 expansion in a family with bipolar disorder. Bipolar Disorders, 15, 326–332.CrossRefPubMedPubMedCentralGoogle Scholar
  32. Paulsen, J. S. (2010). Early detection of Huntington’s disease. Future Neurology, 5, 85–104.CrossRefGoogle Scholar
  33. Paulsen, J. S., Langbehn, D. R., Stout, J. C., Aylward, E., Ross, C. A., Nance, M., Guttman, M., Predict-HD Investigators and Coordinators of the Huntington Study Group, et al. (2008). Detection of Huntington’s disease decades before diagnosis: the Predict-HD study. Journal of Neurology, Neurosurgery and Psychiatry, 79, 874–880.CrossRefPubMedGoogle Scholar
  34. Paulsen, J. S., Nance, M., Kim, J. I., Carlozzi, N. E., Panegyres, P. K., Erwin, C., Goh, A., et al. (2013). A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases. Progress in Neurobiology, 110, 2–28.CrossRefPubMedGoogle Scholar
  35. Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., et al. (2011). Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain, 134, 2456–2477.CrossRefPubMedPubMedCentralGoogle Scholar
  36. Reilmann, R., Leavitt, B. R., & Ross, C. A. (2014). Diagnostic criteria for Huntington’s disease based on natural history. Movement Disorders, 29, 1335–1341.CrossRefPubMedGoogle Scholar
  37. Robins Wahlin, T. B. (2007). To know or not to know: a review of behaviour and suicidal ideation in preclinical Huntington’s disease. Patient Education Counseling, 65, 279–287.CrossRefPubMedGoogle Scholar
  38. Ross, C. A., Aylward, E. H., Wild, E. J., Langbehn, D. R., Long, J. D., Warner, J. H., Scahill, R. I., et al. (2014). Huntington disease: natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology, 10, 204–216.CrossRefPubMedGoogle Scholar
  39. Snowden, J. S., Rollinson, S., Thompson, J. C., Harris, J. M., Stopford, C. L., Richardson, A. M., Jones, M., et al. (2012). Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain, 135, 693–708.CrossRefPubMedPubMedCentralGoogle Scholar
  40. Tabrizi, S. J., Scahill, R. I., Owen, G., Durr, A., Leavitt, B. R., Roos, R. A., Borowsky, B., et al. (2013). Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington’s disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurology, 12, 637–649.CrossRefPubMedGoogle Scholar
  41. Timman, R., Roos, R., Maat-Kievit, A., & Tibben, A. (2004). Adverse effects of predictive testing for Huntington disease underestimated: long-term effects 7–10 years after the test. Health Psychology, 23, 189–197.CrossRefPubMedGoogle Scholar
  42. van der Meer, L. B., van Duijn, E., Wolterbeek, R., & Tibben, A. (2012). Adverse childhood experiences of persons at risk for Huntington’s disease or BRCA1/2 hereditary breast/ovarian cancer. Clinical Genetics, 81, 18–23.CrossRefPubMedGoogle Scholar
  43. van der Meer, L. B., van Duijn, E., Giltay, E. J., & Tibben, A. (2015). Do attachment style and emotion regulation strategies indicate distress in predictive testing? Journal of Genetic Counseling, 24, 862–871.CrossRefPubMedPubMedCentralGoogle Scholar
  44. Watson, A., Pribadi, M., Chowdari, K., Clifton, S., Wood, J., Miller, B. L., Coppola, G., & Nimgaonkar, V. (2016). C9orf72 repeat expansions that cause frontotemporal dementia are detectable among patients with psychosis. Psychiatry Research, 235, 200–202.CrossRefPubMedGoogle Scholar
  45. Woolley, J. D., Khan, B. K., Murthy, N. K., Miller, B. L., & Rankin, K. P. (2011). The diagnostic.challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. Journal of Clinical Psychiatry, 72, 126–133.CrossRefPubMedPubMedCentralGoogle Scholar
  46. Wylie, M. A., Shnall, A., Onyike, C. U., & Huey, E. D. (2013). Management of Frontotemporal dementia in mental health and multidisciplinary settings. International Review of Psychiatry, 25, 230–236.CrossRefPubMedPubMedCentralGoogle Scholar
  47. Zanardini, R., Ciani, M., Benussi, L., & Ghidoni, R. (2016). Molecular pathways bridging frontotemporal lobar degeneration and psychiatric disorders. Frontiers in Aging Neuroscience, 8, 10.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© National Society of Genetic Counselors, Inc. 2016

Authors and Affiliations

  • Jill S. Goldman
    • 1
  • Edward D. Huey
    • 2
    • 3
  • Deborah Z. Thorne
    • 2
  1. 1.Taub InstituteColumbia University Medical CenterNew YorkUSA
  2. 2.Department of NeurologyColumbia University Medical CenterNew YorkUSA
  3. 3.Department of PsychiatryColumbia University Medical CenterNew YorkUSA

Personalised recommendations